Powered by

Kalytera Therapeutics accelerates decline, down 2.0% in 2 days February 01, 2017 17:00 EST

Feb 1, 2017 - News Bites Canadian Markets


Kalytera Therapeutics, Inc. (TSXV:KALY), Canada's 86th largest Oil & gas - exploration & production company by market cap, has decreased 1.0c (2.0%) over the past two trading days, compared with the S&P/TSX 60 Index which fell 2.1 points (0.2%) in the two days for a relative price change of -1.8%. The fall was exacerbated by a cumulative 2-day volume of 6.3 times average daily volume of 43,469 shares. The shares fell 1% on Tuesday and 1% on Wednesday to close at

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox